MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/eurheartj/ehs202

Медицинская библиотека · European heart journal · 2012

Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study.

Charlot Mette, Nielsen Lars Hougaard, Lindhardsen Jesper, Ahlehoff Ole, Olsen Anne-Marie S, Hansen Morten Lock, Hansen Peter Riis, Madsen Jan Kyst, Køber Lars, Gislason Gunnar H, Torp-Pedersen Christian

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

AIMS: The benefit of extending clopidogrel treatment beyond the 12-month period recommended in current guidelines after myocardial infarction (MI) is debated. We analysed the risk of adverse cardiovascular outcomes after discontinuation of 12 months of clopidogrel treatment.

METHODS AND

RESULTS

This Danish retrospective nationwide study included all patients treated with clopidogrel after discharge from a first-time MI during 2004-09. The risk of death or recurrent MI after the discontinuation of clopidogrel was studied by multivariable Poisson regression models. Patients treated with and without percutaneous coronary intervention (PCI) were analysed separately. The follow-up was 18 months. Of the 29,268 patients included, 3214 (11.0%) experienced death or recurrent MI. There were 9819 (33.6%) patients treated only medically and 19,449 (66.4%) patients treated with PCI. Twelve months after the index MI, for patients treated only medically, the risk of death or recurrent MI in the first 90-day period of clopidogrel discontinuation was 1.07 (0.65-1.76; P= 0.79) [adjusted incidence rate ratio (IRR) and 95% confidence interval] compared with the next 90-day period of discontinuation. For patients treated with PCI, the corresponding IRR was 1.59 (1.11-2.30; P= 0.013). The risk of recurrent MI yielded an IRR of 0.77 (0.36-1.67; P= 0.51) for patients treated only medically and 1.87 (1.11-3.15; P= 0.019) for PCI-treated patients.

CONCLUSION

Discontinuation of clopidogrel 12 months after MI is associated with an increased risk of death or recurrent MI in the first 90 days of discontinuation compared with the next 90-day period of discontinuation for patients treated with PCI, but not for patients not treated with PCI.

Для цитирования: Charlot Mette, Nielsen Lars Hougaard, Lindhardsen Jesper, Ahlehoff Ole, Olsen Anne-Marie S, Hansen Morten Lock, Hansen Peter Riis, Madsen Jan Kyst, Køber Lars, Gislason Gunnar H, Torp-Pedersen Christian. Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study.. European heart journal. 2012. DOI: 10.1093/eurheartj/ehs202.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.